| Kossuth Regional Health Center | |
| 1515 South Phillips Street, Algona, Iowa 50511 | |
| (515) 295-2451 | |
| Name | Kossuth Regional Health Center |
|---|---|
| Type | Critical Access Hospital |
| Location | 1515 South Phillips Street, Algona, Iowa |
| Ownership | Government - Local |
| Emergency Services | Yes |
| Medicare ID (CCN) | 161353 |
| NPI Number | 1376614040 |
| Organization Name | KOSSUTH REGIONAL HEALTH CENTER |
| Address | 1515 S Phillips St, Algona, IA 50511 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 515-295-2451 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Tacrolimus Capsules, 0.5 mg, 1 mg and 5 mg, the generic version of Astellas' Prograf® Capsules, a treatment to prevent rejection in people who have received certain organ transplants.
In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies.
Lower health spending because of slower Medicaid enrollment growth is good news for Minnesota's budget. In Virginia, however, Democrats say a GOP budget doesn't spend enough on health care.
New American Diabetes Association (ADA) screening guidelines may lead to the missed diagnoses of type 2 diabetes in children, according to a new study by University of Michigan.
Pregnant women with opioid use disorder (OUD) are more likely to receive evidence-based treatment with an "opioid agonist"- usually methadone- in states where those medications are covered by Medicaid, reports a study in the December issue of Medical Care, published by Wolters Kluwer.
› Verified 4 days ago
| NPI Number | 1679644330 |
| Organization Name | KOSSUTH REGIONAL HEALTH CENTER |
| Address | 1515 S Phillips St, Algona, IA 50511 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 515-295-2451 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Tacrolimus Capsules, 0.5 mg, 1 mg and 5 mg, the generic version of Astellas' Prograf® Capsules, a treatment to prevent rejection in people who have received certain organ transplants.
In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies.
Lower health spending because of slower Medicaid enrollment growth is good news for Minnesota's budget. In Virginia, however, Democrats say a GOP budget doesn't spend enough on health care.
New American Diabetes Association (ADA) screening guidelines may lead to the missed diagnoses of type 2 diabetes in children, according to a new study by University of Michigan.
Pregnant women with opioid use disorder (OUD) are more likely to receive evidence-based treatment with an "opioid agonist"- usually methadone- in states where those medications are covered by Medicaid, reports a study in the December issue of Medical Care, published by Wolters Kluwer.
› Verified 4 days ago
| NPI Number | 1841361276 |
| Organization Name | KOSSUTH REGIONAL HEALTH CENTER |
| Address | 1515 S Phillips St, Algona, IA 50511 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 515-295-2451 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Tacrolimus Capsules, 0.5 mg, 1 mg and 5 mg, the generic version of Astellas' Prograf® Capsules, a treatment to prevent rejection in people who have received certain organ transplants.
In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies.
Lower health spending because of slower Medicaid enrollment growth is good news for Minnesota's budget. In Virginia, however, Democrats say a GOP budget doesn't spend enough on health care.
New American Diabetes Association (ADA) screening guidelines may lead to the missed diagnoses of type 2 diabetes in children, according to a new study by University of Michigan.
Pregnant women with opioid use disorder (OUD) are more likely to receive evidence-based treatment with an "opioid agonist"- usually methadone- in states where those medications are covered by Medicaid, reports a study in the December issue of Medical Care, published by Wolters Kluwer.
› Verified 4 days ago
| NPI Number | 1891869798 |
| Organization Name | KOSSUTH REGIONAL HEALTH CENTER |
| Address | 1515 S Phillips St, Algona, IA 50511 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 515-295-2451 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Tacrolimus Capsules, 0.5 mg, 1 mg and 5 mg, the generic version of Astellas' Prograf® Capsules, a treatment to prevent rejection in people who have received certain organ transplants.
In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies.
Lower health spending because of slower Medicaid enrollment growth is good news for Minnesota's budget. In Virginia, however, Democrats say a GOP budget doesn't spend enough on health care.
New American Diabetes Association (ADA) screening guidelines may lead to the missed diagnoses of type 2 diabetes in children, according to a new study by University of Michigan.
Pregnant women with opioid use disorder (OUD) are more likely to receive evidence-based treatment with an "opioid agonist"- usually methadone- in states where those medications are covered by Medicaid, reports a study in the December issue of Medical Care, published by Wolters Kluwer.
› Verified 4 days ago
| Able to receive lab results electronically | No |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Tacrolimus Capsules, 0.5 mg, 1 mg and 5 mg, the generic version of Astellas' Prograf® Capsules, a treatment to prevent rejection in people who have received certain organ transplants.
In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies.
Lower health spending because of slower Medicaid enrollment growth is good news for Minnesota's budget. In Virginia, however, Democrats say a GOP budget doesn't spend enough on health care.
New American Diabetes Association (ADA) screening guidelines may lead to the missed diagnoses of type 2 diabetes in children, according to a new study by University of Michigan.
Pregnant women with opioid use disorder (OUD) are more likely to receive evidence-based treatment with an "opioid agonist"- usually methadone- in states where those medications are covered by Medicaid, reports a study in the December issue of Medical Care, published by Wolters Kluwer.
› Verified 4 days ago
Kossuth Regional Health Center Critical Access Hospital Location: 1515 South Phillips Street, Algona, Iowa 50511 Phone: (515) 295-2451 |